52 results on '"Morris, Alanna A."'
Search Results
2. ASSOCIATION OF PROVIDER ASSESSED PSYCHOSOCIAL RISK AND FRAILTY WITH OUTCOMES IN DESTINATION THERAPY LEFT VENTRICULAR ASSIST DEVICE PATIENTS.
3. Influence of Race/Ethnic Differences in Pre-Transplantation Panel Reactive Antibody on Outcomes in Heart Transplant Recipients.
4. Implications of Atrial Fibrillation for Guideline-Directed Therapy in Patients With Heart Failure: JACC State-of-the-Art Review.
5. ASSOCIATION OF MEDICAID EXPANSIONS WITH ACCESS TO HEART TRANSPLANTATION AND VENTRICULAR ASSIST DEVICE THERAPY.
6. Screening for Dilated Cardiomyopathy in At-Risk First-Degree Relatives.
7. Reply: Ethnic Diversity and Immunological Barriers in Heart Transplantation.
8. Albuminuria and Heart Failure: JACC State-of-the-Art Review.
9. RACIAL DIFFERENCES IN DIGITAL REACTIVE HYPEREMIA MEASURED BY PULSE VOLUME AMPLITUDE: THE META-HEALTH STUDY
10. OXIDATIVE STRESS IS ASSOCIATED WITH REDUCED GLOMERULAR FILTRATION RATE IN A POPULATION WITH PRESERVED RENAL FUNCTION: THE META-HEALTH STUDY
11. SOCIAL DISPARITIES, EXPERIENCES WITH DISCRIMINATION, AND CARDIOVASCULAR PHENOTYPES IN BLACK AND WHITE COLLEGIATE AMERICAN-STYLE FOOTBALL ATHLETES.
12. THE INDEPENDENT AND JOINT IMPACT OF DIABETES AND HYPERTENSION ON INCIDENT CARDIOVASCULAR DISEASE: A POOLED COHORT ANALYSIS.
13. SOCIAL DETERMINANTS IMPROVE PREDICTION OF 30-DAY READMISSION IN BLACK AND WHITE PATIENTS HOSPITALIZED FOR HEART FAILURE.
14. RELATIONSHIP OF INTERLEUKIN-6 BEFORE AND AFTER MENTAL STRESS CHALLENGE WITH HEART FAILURE IN INDIVIDUALS WITH STABLE CORONARY ARTERY DISEASE.
15. CLINICAL TRIAL INCLUSION AND IMPACT ON EARLY ADOPTION OF MEDICAL INNOVATION IN DIVERSE POPULATIONS: A REAL-WORLD CASE STUDY IN PATIENTS WITH HEART FAILURE.
16. RACIAL AND ETHNIC DISPARITIES IN REFERRAL TO OUTPATIENT HEART FAILURE MANAGEMENT AT HOSPITAL DISCHARGE: A GET WITH THE GUIDELINES ANALYSIS.
17. OUT-OF-POCKET COSTS FOR HEART FAILURE THERAPIES BY PAYOR TYPE.
18. A DESCRIPTION OF PROCESSES EMPLOYED AND CHALLENGES ENCOUNTERED TO OBTAIN PATIENT OUT-OF-POCKET COSTS FOR THE POCKET-COST-HF TRIAL.
19. Race and Ethnicity in Heart Failure: JACC Focus Seminar 8/9.
20. ACC Health Policy Statement on Cardiovascular Disease Considerations for COVID-19 Vaccine Prioritization: A Report of the American College of Cardiology Solution Set Oversight Committee.
21. 2019 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Recommendations and Requirements for Transcatheter Mitral Valve Intervention: A Joint Report of the American Association for Thoracic Surgery, the American College of Cardiology, the Society for Cardiovascular Angiography and Interventions, and The Society of Thoracic Surgeons.
22. 2020 Focused Update of the 2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation: A Report of the American College of Cardiology Solution Set Oversight Committee.
23. CLINICAL PREDICTORS OF ONE-YEAR TRAJECTORY OF EJECTION FRACTION IN PATIENTSWITH HFMREF.
24. WILL MY PATIENT WITH ACUTE HEART FAILURE NEED TRANSFER TO THE INTENSIVE CARE UNIT? A PREDICTIVE MODEL FOR INPATIENT WORSENING HEART FAILURE.
25. SEX ASSOCIATED DIFFERENCES IN CLINICAL OUTCOMES AMONG LEFT VENTRICULAR ASSIST DEVICE RECIPIENTS: INSIGHTS FROM INTERMACS.
26. HEART RATE VARIABILITY DURING MENTAL STRESS PREDICTS HEART FAILURE OUTCOMES IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE.
27. PSYCHOSOCIAL RISK FACTORS ARE ASSOCIATED WITH WORSE QUALITY OF LIFE 1-YEAR AFTER LVAD IMPLANTATION.
28. UTILIZATION AND OUTCOMES OF GUIDELINE DIRECTED MEDICAL THERAPY IN FRAIL PATIENTS HOSPITALIZED FOR HEART FAILURE WITH REDUCED EJECTION FRACTION.
29. Quality and Equitable Health Care Gaps for Women: Attributions to Sex Differences in Cardiovascular Medicine.
30. 2017 ACC/AHA/HFSA/ISHLT/ACP Advanced Training Statement on Advanced Heart Failure and Transplant Cardiology (Revision of the ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant): A Report of the ACC Competency Management Committee.
31. PREDICTION OF RACIAL DIFFERENCES IN SUB-CLINICAL VASCULAR DISEASE IN AFRICAN AMERICANS AND WHITES: COMPARISON OF THE FRAMINGHAM AND THE ATHEROSCLEROTIC CARDIOVASCULAR RISK SCORES.
32. CLINICAL OUTCOMES OF PATIENTS WITH PERIPARTUM CARDIOMYOPATHY LISTED FOR HEART TRANSPLANTATION.
33. NATRIURESIS IS LOWER IN BLACK PATIENTS WITH ACUTE HEART FAILURE: A POST HOC ANALYSIS OF ROSE-AHF.
34. RECLASSIFICATION OF METABOLIC SYNDROME FROM ADULT TREATMENT PANEL III TO WORLD HEALTH ORGANIZATION CRITERIA IS ASSOCIATED WITH CHANGES IN ARTERIAL STIFFNESS
35. Vitamin D Status Is Associated With Arterial Stiffness and Vascular Dysfunction in Healthy Humans
36. THE EFFECT OF OUT-OF-POCKET COST DISCUSSIONS ON WILLINGNESS TO TAKE SACUBITRIL VALSARTAN FOR HEART FAILURE.
37. GEOGRAPHIC DIFFERENCES IN WAITLIST AND POST-TRANSPLANT OUTCOMES AFTER THE 2018 US HEART ALLOCATION SYSTEM.
38. PREDICTORS OF LIKELIHOOD OF TAKING SACUBITRIL-VALSARTAN AND A HYPOTHETICAL MEDICATION FOR COVID-19.
39. THE EFFECT OF OUT-OF-POCKET COST DISCUSSIONS ON WILLINGNESS TO TAKE SACUBITRIL VALSARTAN FOR HEART FAILURE.
40. GEOGRAPHIC DIFFERENCES IN WAITLIST AND POST-TRANSPLANT OUTCOMES AFTER THE 2018 US HEART ALLOCATION SYSTEM.
41. PREDICTORS OF LIKELIHOOD OF TAKING SACUBITRIL-VALSARTAN AND A HYPOTHETICAL MEDICATION FOR COVID-19.
42. AREA DEPRIVATION INDEX IS MORE STRONGLY ASSOCIATED WITH THE RISK OF RECURRENT HEART FAILURE HOSPITALIZATION IN WHITES THAN BLACKS.
43. L-LEUCINE: A NOVEL BIOMARKER THAT PREDICTS LOWER MORTALITY IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION.
44. SEX DIFFERENCES IN ELIGIBILITY FOR ADVANCED HEART FAILURE THERAPIES.
45. A SCORE COMPRISED OF NOVEL METABOLITES RELATED TO MYOCARDIAL ENERGETICS IS ASSOCIATED WITH SEX DISPARITIES IN HEART FAILURE OUTCOMES.
46. IMPACT OF INSURANCE TYPE ON ELIGIBILITY FOR ADVANCED HEART FAILURE THERAPIES AND SURVIVAL.
47. DISCUSSING OUT-OF-POCKET COSTS WITH PATIENTS: SHARED DECISION-MAKING FOR SACUBUTRIL-VALSARTAN IN CONGESTIVE HEART FAILURE.
48. LIVING IN A FOOD DESERT IS ASSOCIATED WITH AN EARLY HAZARD OF DEATH AND HOSPITALIZATION IN HEART FAILURE PATIENTS.
49. AMBULATORY ACTIGRAPHY MONITORING OF PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION PREDICTS 6-MINUTE WALK DISTANCE.
50. INTERMACS PROFILES AND MORTALITY AMONG AMBULATORY PATIENTS WITH SYSTOLIC HEART FAILURE.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.